OrthoPediatrics Corp (KIDS) Operating Margin
- Operating margin · 12 months: Value -11.87%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | -11.87% | Operating income / revenue. Period ending 2026-06-30. $-30.00M ÷ $252.72M × 100 ≈ -11.87% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -30.00M USD | Operating Income (Loss) |
| Revenue | 252.72M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | 66.59M USD | Cost of Goods and Services Sold |
| Research and development | 9.15M USD | Research and Development Expense |
| Selling, general and administration | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $-30.00M | $252.72M | $66.59M | $9.15M | (m) | -11.87% |
| 2026-03-31 | $-36.59M | $243.30M | $65.51M | $8.98M | (m) | -15.04% |
| 2025-12-31 | $-39.24M | $236.35M | $63.69M | $9.10M | (m) | -16.60% |
| 2025-09-30 | $-45.12M | $227.41M | $64.29M | $9.76M | (m) | -19.84% |
| 2025-06-30 | $-41.26M | $220.73M | $62.83M | $10.00M | (m) | -18.69% |
| 2025-03-31 | $-36.27M | $212.45M | $57.77M | $10.39M | (m) | -17.07% |
| 2024-12-31 | $-35.01M | $204.73M | $56.13M | $11.03M | (m) | -17.10% |
| 2024-09-30 | $-29.02M | $189.67M | $49.93M | $10.34M | (m) | -15.30% |
| 2024-06-30 | $-27.96M | $175.07M | $44.43M | $10.32M | (m) | -15.97% |
| 2024-03-31 | $-27.88M | $161.83M | $41.96M | $10.75M | (m) | -17.23% |
| 2023-12-31 | $-26.75M | $148.73M | $37.48M | $10.20M | (m) | -17.99% |
| 2023-09-30 | $-26.99M | $142.11M | $36.35M | $9.48M | (m) | -18.99% |
| 2023-06-30 | $-29.45M | $137.09M | $36.39M | $9.30M | (m) | -21.48% |
| 2023-03-31 | $-27.60M | $130.46M | $34.80M | $8.26M | (m) | -21.16% |
| 2022-12-31 | $-25.40M | $122.29M | $31.63M | $8.01M | (m) | -20.77% |
| 2022-09-30 | $-22.65M | $116.11M | $28.59M | $7.59M | (m) | -19.51% |
| 2022-06-30 | $-19.33M | $106.24M | $26.05M | $6.68M | (m) | -18.20% |
| 2022-03-31 | $-18.44M | $100.00M | $24.36M | $6.26M | (m) | -18.44% |
| 2021-12-31 | $-18.02M | $98.05M | $24.65M | $5.54M | (m) | -18.38% |
| 2021-09-30 | $-25.21M | $92.16M | $21.72M | $5.99M | (m) | -27.35% |
| 2021-06-30 | $-24.06M | $89.29M | $19.76M | $5.76M | (m) | -26.95% |
| 2021-03-31 | $-28.23M | $76.18M | $17.04M | $5.32M | (m) | -37.06% |
| 2020-12-31 | $-26.75M | $71.08M | $16.05M | $5.27M | (m) | -37.64% |
| 2020-09-30 | $-17.04M | $71.11M | $16.74M | $5.13M | (m) | -23.97% |
| 2020-06-30 | $-16.08M | $69.64M | $17.03M | $5.45M | (m) | -23.09% |
| 2020-03-31 | $-10.86M | $74.25M | $18.07M | $5.80M | (m) | -14.62% |
| 2019-12-31 | $-9.08M | $72.55M | $17.93M | $5.75M | (m) | -12.51% |
| 2019-09-30 | $-7.91M | $68.17M | $17.48M | $5.12M | (m) | -11.61% |
| 2019-06-30 | $-7.54M | $63.24M | $16.48M | $4.85M | (m) | -11.93% |
| 2019-03-31 | $-7.88M | $60.12M | $15.71M | $4.73M | (m) | -13.10% |
| 2018-12-31 | $-9.55M | $57.56M | $14.88M | $4.73M | (m) | -16.60% |
| 2018-09-30 | $-11.89M | $54.67M | (m) | $4.40M | (m) | -21.75% |
| 2018-06-30 | $-11.47M | $51.23M | (m) | $4.40M | (m) | -22.40% |
| 2018-03-31 | $-10.03M | $47.95M | (m) | $3.95M | (m) | -20.92% |
| 2017-12-31 | $-6.47M | $45.62M | (m) | $3.42M | (m) | -14.19% |
| 2017-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-06-30 | $-5.29M | $41.12M | (m) | (m) | (m) | -12.87% |
| 2017-03-31 | $-5.48M | $38.99M | (m) | (m) | (m) | -14.05% |
| 2016-12-31 | $-6.13M | $37.30M | (m) | $2.22M | (m) | -16.43% |
| 2016-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-12-31 | $-6.59M | $31.00M | (m) | $1.79M | (m) | -21.26% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| CARLSMED, INC. (CARL) | United States | $0.405B |